The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase

被引:61
作者
Wang, XD [1 ]
Gjörloff-Wingren, A [1 ]
Saxena, M [1 ]
Pathan, N [1 ]
Reed, JC [1 ]
Mustelin, T [1 ]
机构
[1] La Jolla Canc Res Ctr, Burnham Inst, Lab Signal Transduct, La Jolla, CA 92037 USA
关键词
D O I
10.4049/jimmunol.164.4.1934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor suppressor gene PTEN encodes a 55-kDa enzyme that hydrolyzes both protein phosphotyrosyl and 3-phosphorylated inositol phospholipids in vitro. We have found that the latter activity is physiologically relevant in intact T cells. Expression of active PTEN lead to a 50% loss of transfected cells due to increased apoptosis, which was completely prevented by coexpression of a constitutively active, membrane-bound form of protein kinase B. A mutant of PTEN selectively lacking lipid phosphatase activity, but retaining protein phosphatase activity, had no effects on cell number. Active (but not mutant) PTEN also decreased TCR-induced activation of the mitogen-activated protein kinase ERK2 (extracellular signal-related kinase 2), as seen after inhibition of phosphatidylinositol 3-kinase, Our data indicate that PTEN is a phosphatidylinositol 3-phosphatase in T cells, and we suggest that PTEN may play a role in the regulation of T cell survival and TCR signaling by directly opposing phosphatidylinositol 3-kinase.
引用
收藏
页码:1934 / 1939
页数:6
相关论文
共 27 条
[11]   PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J].
Li, J ;
Yen, C ;
Liaw, D ;
Podsypanina, K ;
Bose, S ;
Wang, SI ;
Puc, J ;
Miliaresis, C ;
Rodgers, L ;
McCombie, R ;
Bigner, SH ;
Giovanella, BC ;
Ittmann, M ;
Tycko, B ;
Hibshoosh, H ;
Wigler, MH ;
Parsons, R .
SCIENCE, 1997, 275 (5308) :1943-1947
[12]   Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome [J].
Liaw, D ;
Marsh, DJ ;
Li, J ;
Dahia, PLM ;
Wang, SI ;
Zheng, ZM ;
Bose, S ;
Call, KM ;
Tsou, HC ;
Peacocke, M ;
Eng, C ;
Parsons, R .
NATURE GENETICS, 1997, 16 (01) :64-67
[13]   The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate [J].
Maehama, T ;
Dixon, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13375-13378
[14]   Germline mutations in PTEN are present in Bannayan-Zonana syndrome [J].
Marsh, DJ ;
Dahia, PLM ;
Zheng, ZM ;
Liaw, D ;
Parsons, R ;
Gorlin, RJ ;
Eng, C .
NATURE GENETICS, 1997, 16 (04) :333-334
[15]   P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase [J].
Myers, MP ;
Stolarov, JP ;
Eng, C ;
Li, J ;
Wang, SI ;
Wigler, MH ;
Parsons, R ;
Tonks, NK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9052-9057
[16]   The lipid phosphatase activity of PTEN is critical for its tumor suppressor function [J].
Myers, MP ;
Pass, I ;
Batty, IH ;
Van der Kaay, J ;
Stolarov, JP ;
Hemmings, BA ;
Wigler, MH ;
Downes, CP ;
Tonks, NK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13513-13518
[17]   Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway [J].
Ramaswamy, S ;
Nakamura, N ;
Vazquez, F ;
Batt, DB ;
Perera, S ;
Roberts, TM ;
Sellers, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2110-2115
[18]  
Rhei E, 1997, CANCER RES, V57, P3657
[19]   Cancer predisposition: Where's the phosphate? [J].
Smith, A ;
Ashworth, A .
CURRENT BIOLOGY, 1998, 8 (07) :R241-+
[20]   RECURRENT ABNORMALITIES OF CHROMOSOME BANDS 10Q23-25 IN NON-HODGKINS-LYMPHOMA [J].
SPEAKS, SL ;
SANGER, WG ;
MASIH, AS ;
HARRINGTON, DS ;
HESS, M ;
ARMITAGE, JO .
GENES CHROMOSOMES & CANCER, 1992, 5 (03) :239-243